IBRX is trading at $7.58, up 5.1% versus the comparison close of $7.22 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this follow-up.
🟢 IBRX extends move to 5.1% up
Immunitybio Inc
Related News
IBRX
ImmunityBio Reports 71% Complete Response Rate in Bladder Cancer Trial
IBRX
🔴 Immunitybio is trading 5% down today amid biotech sector weakness
IBRX
🟢 Immunitybio is trading 5.65% up today after FDA expanded ANKTIVA approval for bladder cancer treatment
IBRX
IBRX Receives Expanded FDA Approval for ANKTIVA in Bladder Cancer Treatment
IBRX